Abbott Laboratories Valuation

Q: What is the Fair Price of ABT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

ABT (ARS32600) is trading above our estimate of [[fair value]] (ARS32432.5)

Is ABT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ABT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ABT (ARS32600) is trading above our estimate of fair value (ARS32432.5)

Significantly Below Fair Value: ABT is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ABT?

Key metric: As ABT is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ABT. This is calculated by dividing ABT's market cap by their current earnings.
What is ABT's PE Ratio?
PE Ratio	35.4x
Earnings	US$5.74b
Market Cap	US$203.56b

ABT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	5.1x
Enterprise Value/EBITDA	19.5x
PEG Ratio	3x

Price to Earnings Ratio vs Peers

How does ABT's PE Ratio compare to its peers?

The above table shows the PE ratio for ABT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	57.2x
ISRG Intuitive Surgical	85.6x	11.5%	US$189.4b
SYK Stryker	41.3x	11.4%	US$148.4b
MDT Medtronic	27.8x	11.4%	US$112.3b
BSX Boston Scientific	74.3x	23.2%	US$133.3b
ABT Abbott Laboratories	35.4x	11.6%	AR$203.6b

Price-To-Earnings vs Peers: ABT is good value based on its Price-To-Earnings Ratio (35.4x) compared to the peer average (57.2x).

Price to Earnings Ratio vs Industry

How does ABT's PE Ratio compare vs other companies in the Global Medical Equipment Industry?

10 Companies	Price / Earnings	Estimated Growth	Market Cap

10 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: ABT is expensive based on its Price-To-Earnings Ratio (35.4x) compared to the Global Medical Equipment industry average (27.7x).

Price to Earnings Ratio vs Fair Ratio

What is ABT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ABT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	35.4x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ABT's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.